• Schedule 13D/G History

Brii Biosciences Ltd - Significant Ownership

Signature - Title
Brii Biosciences Limited - Ankang Li, Executive Director, Chief Strategy and Financial Officer
Location
Durham, NC
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Brii Biosciences Ltd.

Significant Ownership of Brii Biosciences Ltd

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ANTX AN2 THERAPEUTICS, INC. Common Stock, $0.00001 par value per share 3.1% $1.26M 927K Brii Biosciences Limited Dec 31, 2024

Schedules 13D/G Reported by Brii Biosciences Ltd:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Date Filed
* An asterisk sign (*) next to the price indicates that the price is likely invalid.